focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 22.50
Bid: 22.00
Ask: 23.00
Change: -0.75 (-3.23%)
Spread: 1.00 (4.545%)
Open: 24.25
High: 24.50
Low: 22.50
Prev. Close: 23.25
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Berenberg cuts Anglo American and Gem Diamonds

Thu, 06th Oct 2022 10:46

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

----------

FTSE 100

----------

Bank of America raises Admiral Group price target to 2,000 (1,960) pence - 'underperform'

----------

Bank of America cuts Prudential price target to 1,360 (1,455) pence - 'buy'

----------

Bank of America cuts Aviva price target to 480 (500) pence - 'neutral'

----------

Bank of America cuts Hargreaves Lansdown price target to 1,050 (1,100) pence - 'buy'

----------

Bank of America cuts M&G price target to 222 (245) pence - 'buy'

----------

Deutsche Bank cuts M&G price target to 200 (230) pence - 'hold'

----------

Bank of America cuts Phoenix Group price target to 725 (800) pence - 'buy'

----------

HSBC raises Legal & General price target to 350 (335) pence - 'buy'

----------

Bank of America cuts Legal & General price target to 280 (315) pence - 'buy'

----------

Deutsche Bank cuts St James's Place target to 1,370 (1,420) pence - 'buy'

----------

Bank of America cuts St James's Place price target to 1,300 (1,435) pence - 'neutral'

----------

RBC raises Segro to 'outperform' (sector perform) - price target 900 (1,075) pence

----------

RBC cuts British Land price target to 330 (375) pence - 'sector perform'

----------

RBC cuts Land Securities price target to 550 (650) pence - 'sector perform'

----------

Goldman Sachs raises Standard Chartered price target to 890 (870) pence - 'buy'

----------

Goldman Sachs raises HSBC price target to 750 (705) pence - 'neutral'

----------

UBS cuts Intertek price target to 6,000 (6,500) pence - 'buy'

----------

UBS cuts RS Group price target to 1,300 (1,375) pence - 'buy'

----------

UBS cuts Experian price target to 3,200 (3,400) pence - 'buy'

----------

Goldman Sachs cuts Auto Trader Group price target to 621 (625) pence - 'neutral'

----------

HSBC cuts Auto Trader Group price target to 740 (795) pence - 'buy'

----------

Goldman Sachs cuts Tesco price target to 245 (255) pence - 'buy'

----------

Credit Suisse cuts Tesco price target to 238 (292) pence - 'neutral'

----------

Credit Suisse cuts Sainsbury price target to 184 (231) pence - 'underperform'

----------

Goldman Sachs cuts Next price target to 5,750 (7,600) pence - 'neutral'

----------

RBC raises Burberry price target to 1,800 (1,700) pence - 'sector perform'

----------

Goldman Sachs raises Burberry price target to 2,490 (2,410) pence - 'buy'

----------

Exane BNP starts Entain with 'outperform' - price target 13,500 pence

----------

Exane BNP starts Flutter with 'outperform' - price target 12,500 pence

----------

Deutsche Bank cuts Reckitt price target to 6,900 (7,200) pence - 'buy'

----------

Berenberg cuts Anglo American to 'hold' (buy) - price target 3,000 (3,200) pence

----------

Berenberg cuts Endeavour Mining price target to 2,900 (3,000) pence - 'buy'

----------

Berenberg raises Fresnillo price target to 800 (700) pence - 'hold'

----------

Berenberg cuts Rio Tinto price target to 4,000 (4,300) pence - 'sell

----------

FTSE 250

----------

Berenberg cuts Sirius Real Estate price target to 123 (150) pence - 'buy'

----------

RBC cuts Great Portland price target to 470 (485) pence - 'underperform'

----------

RBC cuts Workspace Group price target to 600 (675) pence - 'outperform'

----------

RBC cuts Derwent London price target to 2,000 (2,100) pence - 'underperform'

----------

RBC cuts Hammerson price target to 15.5 (16.5) pence - 'underperform'

----------

RBC cuts Big Yellow Group price target to 1,100 (1,200) pence - 'underperform'

----------

RBC cuts Warehouse REIT price target to 115 (120) pence - 'underperform'

----------

RBC cuts Tritax Eurobox price target to 90 (105) pence - 'outperform'

----------

RBC cuts Tritax Big Box price target to 190 (205) pence - 'outperform'

----------

RBC cuts LondonMetric Property price target to 245 (270) pence - 'outperform'

----------

Barclays cuts Computacenter price target to 2,385 (2,900) pence - 'equal weight'

----------

Barclays cuts Babcock International target to 325 (358) pence - 'equal weight'

----------

Jefferies cuts Spire Healthcare price target to 240 (251) pence - 'hold'

----------

Jefferies cuts Johnson Matthey price target to 2,300 (2,400) pence - 'buy'

----------

Numis cuts Synthomer to 'hold' ('add') - target 120 (230) pence

----------

Berenberg raises Centamin price target to 114 (112) pence - 'buy'

----------

UBS cuts Serco price target to 190 (210) pence - 'buy'

----------

Barclays cuts Renishaw price target to 3,520 (3,975) pence - 'underweight'

----------

Berenberg cuts John Wood price target to 180 (270) pence - 'buy'

----------

UBS cuts Hays price target to 160 (220) pence - 'buy'

----------

Bank of America cuts Quilter price target to 104 (115) pence - 'underperform'

----------

Bank of America cuts Direct Line price target to 185 (195) pence - 'underperform'

----------

JPMorgan cuts Close Brothers price target to 1,240 (1,370) pence - 'neutral'

----------

Bank of America cuts Ninety One price target to 215 (220) pence - 'neutral'

----------

Bank of America raises Man Group price target to 305 (300) pence - 'buy'

----------

Bank of America cuts Jupiter Fund price target to 85 (115) pence - 'underperform'

----------

Bank of America cuts Ashmore Group price target to 175 (185) pence - 'underperform'

----------

Deutsche Bank cuts abrdn price target to 125 (135) pence - 'sell'

----------

Credit Suisse cuts Moneysupermarket target to 202 (208) pence - 'neutral'

----------

SMALL CAP

----------

UBS cuts Just Eat Takeaway price target to 2,200 (2,400) pence - 'buy'

----------

Berenberg raises Yellow Cake price target to 600 (500) pence - 'buy'

----------

Berenberg raises Yamana Gold price target to 660 (640) pence - 'buy'

----------

Berenberg cuts Resolute Mining price target to 48 (49) pence - 'buy'

----------

Berenberg cuts Tharisa price target to 250 (270) pence - 'buy'

----------

Berenberg raises Sovereign Metals price target to 84 (75) pence - 'buy'

----------

Berenberg cuts Jubilee Metals price target to 19 (20) pence - 'buy'

----------

Berenberg cuts Hochschild Mining price target to 90 (100) pence - 'hold'

----------

Berenberg cuts Griffin Mining price target to 140 (160) pence - 'buy'

----------

Berenberg cuts Central Asia Metals price target to 280 (300) pence - 'buy'

----------

Berenberg raises BHP Group price target to 2,300 (2,100) pence - 'hold'

----------

Berenberg cuts Atalaya Mining price target to 310 (370) pence - 'buy'

----------

Berenberg cuts Anglo Pacific Group price target to 330 (390) pence - 'buy'

----------

Berenberg raises Petra Diamonds to 'buy' (hold) - price target 200 (130) pence

----------

Berenberg cuts Gem Diamonds to 'hold' (buy) - price target 40 (60) pence

----------

RBC raises Empiric Student Property target to 90 (84) pence - 'sector perform'

----------

Jefferies cuts Angle price target to 170 (200) pence - 'buy'

----------

Bank of America cuts Old Mutual price target to 68.50 (76) pence - 'buy'

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
30 Mar 2021 15:39

Angle completes clinical labs in Guildford and Pennsylvania

(Sharecast News) - Liquid biopsy company Angle has completed the fitout and staffing of its clinical services laboratories in Guildford and Pennsylvania, it announced on Tuesday.

Read more
4 Mar 2021 19:32

TRADING UPDATES: Futura signs development deal; UKOG gets day in court

TRADING UPDATES: Futura signs development deal; UKOG gets day in court

Read more
4 Mar 2021 11:42

AIM WINNERS & LOSERS: Futura Medical rises on financing transaction

AIM WINNERS & LOSERS: Futura Medical rises on financing transaction

Read more
18 Feb 2021 10:24

Angle Shares Jump On Recent Parsortix System Research Results

Angle Shares Jump On Recent Parsortix System Research Results

Read more
8 Feb 2021 17:09

IN BRIEF: Angle Says Athens University Study Shows Value Of Parsortix

IN BRIEF: Angle Says Athens University Study Shows Value Of Parsortix

Read more
29 Jan 2021 18:26

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash

Read more
20 Jan 2021 12:22

Angle Reports Parsortix System Can Isolate Circulating Tumour Cells

Angle Reports Parsortix System Can Isolate Circulating Tumour Cells

Read more
20 Jan 2021 10:40

LONDON AIM WINNERS & LOSERS: Sabien Sinks On Ptarmigan Deal Withdrawal

LONDON AIM WINNERS & LOSERS: Sabien Sinks On Ptarmigan Deal Withdrawal

Read more
3 Nov 2020 15:53

DIRECTOR DEALINGS: Angle Chair And Finance Director Buys 60,000 Shares

DIRECTOR DEALINGS: Angle Chair And Finance Director Buys 60,000 Shares

Read more
29 Oct 2020 14:46

UK EARNINGS SUMMARY: Gfinity Continues Review Including Possible Sale

UK EARNINGS SUMMARY: Gfinity Continues Review Including Possible Sale

Read more
27 Oct 2020 19:06

UPDATE: Angle Successfully Raises GBP20 Million In Placing

UPDATE: Angle Successfully Raises GBP20 Million In Placing

Read more
27 Oct 2020 12:37

IN BRIEF: Angle To Raise GBP20 Million To Fund Operations

IN BRIEF: Angle To Raise GBP20 Million To Fund Operations

Read more
22 Oct 2020 16:01

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
20 Oct 2020 14:18

IN BRIEF: Angle Says FDA Accepts Parsotix Submission For Breast Cancer

IN BRIEF: Angle Says FDA Accepts Parsotix Submission For Breast Cancer

Read more
20 Oct 2020 08:58

FDA accepts Angle's review submission for Parsortix PC1

(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that the US Food and Drug Administration (FDA) has completed its administrative review, and accepted the company's submission for substantive review.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.